| Literature DB >> 21253489 |
Jorge Escobar1, Lorena Varela-Nallar, Claudio Coddou, Pablo Nelson, Kevin Maisey, Daniel Valdés, Alexis Aspee, Victoria Espinosa, Carlos Rozas, Margarita Montoya, Cristian Mandiola, Felipe E Rodríguez, Claudio Acuña-Castillo, Alejandro Escobar, Ricardo Fernández, Hernán Diaz, Mario Sandoval, Mónica Imarai, Miguel Rios.
Abstract
Arsenic has been associated with multiple harmful effects at the cellular level. Indirectly these defects could be related to impairment of the integrity of the immune system, in particular in lymphoid population. To characterize the effect of Arsenic on redox status on this population, copper smelter workers and arsenic unexposed donors were recruited for this study. We analyzed urine samples and lymphocyte enriched fractions from donors to determinate arsenic levels and lymphocyte proliferation. Moreover, we studied the presence of oxidative markers MDA, vitamin E and SOD activity in donor plasma. Here we demonstrated that in human beings exposed to high arsenic concentrations, lymphocyte MDA and arsenic urinary levels showed a positive correlation with SOD activity, and a negative correlation with vitamin E serum levels. Strikingly, lymphocytes from the arsenic exposed population respond to a polyclonal stimulator, phytohemaglutinin, with higher rates of thymidine incorporation than lymphocytes of a control population. As well, similar in vitro responses to arsenic were observed using a T cell line. Our results suggest that chronic human exposure to arsenic induces oxidative damage in lymphocytes and could be considered more relevant than evaluation of T cell surveillance.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21253489 PMCID: PMC3022209 DOI: 10.1155/2010/403830
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Comparative effect of arsenic exposure on the proliferation of lymphocytes isolated from low- and high-As-exposure human populations. Correlation of lymphocyte proliferation and urinary excretion of As from highly As-exposed population. (a) Proliferation was assessed by comparison of 3H-Thymidine incorporation ([3H]-TdR, cpm) in lymphocytes isolated from the low-As-exposure group (control group, n = 31) and from the high-As-exposure group (n = 50). Statistically significant differences were found between the two groups (U-Mann-Whitney test P = .0138). (b) Relationship between 3H-Thymidine incorporation and arsenic concentration in urine (ppm) of the highly exposed population (n = 50). Association between the two variables was determined by R-Pearson (P = .002).
Figure 2Comparative effect of arsenic exposure on lipid peroxidation in blood samples from low- and high-exposure human populations. (a) Comparison of MDA distribution profile in blood samples isolated from low-As-exposure (control, n = 31) and high-As-exposure (n = 50) human populations. Lipid peroxidation was assessed by plasma MDA concentration. The statistical analysis indicates significant differences between the two groups (test U-Mann-Whitney P < .0001). (b) Correlation between MDA concentration and urinary excretion of As in the high As-exposure population (n = 50). The associations between the two variables were determined by R-Pearson (P < .0001).
Figure 3Comparative levels of vitamin E in plasma samples from low- and high-exposure human populations and correlation between plasma vitamin E concentration and urinary excretion of As from highly As-exposed population. (a) Vitamin E concentration profile in the plasma of the low-As-exposure group (n = 31) and the high-As-exposure group (n = 50). The statistical analysis indicates significant differences between the two groups (U-Mann-Whitney test P < .0001). (b) Relationship between plasma vitamin E concentration (μM) and As concentration in urine (ppm) from the highly exposed population. The relationship between the two variables was determined by R-Pearson (P < .0018).
Figure 4Comparative levels of SOD activity in plasma samples from low- and high-exposure human populations and correlation between SOD activity and urinary excretion of As from highly As-exposed population. (a) SOD activity in the plasma samples of the low-As-exposure group (n = 31) and high-As-exposure group (n = 50). Data are graphed as mean standard error (P < .0001). (b) Relationship between plasma SOD activity and As concentration in urine from highly exposed population (P < .0001). Statistical differences of SOD activity between the groups were established according to U-Mann-Whitney test.
Figure 5Effect of sodium arsenite on Jurkat cells. (a) Inhibition of proliferation of PHA-stimulated Jurkat cells by sodium arsenite. Cells (2 × 105 cells/well) were incubated as indicated before, and proliferation was assessed by [3H]-TdR incorporation. Results are expressed in counts per minute (cpm) in the absence and presence of different sodium arsenite concentrations. (b) Evaluation of proliferation of cells (2 × 105 cells/well) stimulated with 5 μg/ml PHA for 48 h. Results are expressed as the number of cells obtained in the presence of different sodium arsenite concentrations in the culture media. (c) Lipid peroxidation in Jurkat cells induced by arsenic. Cells (2 × 105 cells/well) were incubated with sodium arsenite for 48 h and the level of lipid peroxides was measured in the homogenates as MDA concentration.